SUVEN LIFE SCIENCES LTD. - 530239 - Clarification
With reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded, Suven Life Sciences Ltd has submitted to BSE a copy of Clarification is enclosed. SUVEN LIFE SCIENCES LTD. - 530239 - Clarification sought from Suven Life Sciences Ltd
The Exchange has sought clarification from Suven Life Sciences Ltd on December 16, 2020 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited. SUVEN LIFE SCIENCES LTD. - 530239 - Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 ("Listing Regulations")
Pursuant to Regulation 23(9) of Listing Regulations, please find enclosed disclosure of related party transactions on a consolidated basis and balances for the half-year ended September 30th, 2020. We request you to take this document on your record. SUVEN LIFE SCIENCES LTD. - 530239 - Transfer Of Securities In Physical Mode
Pursuant to the SEBI circular SEBI/HO/MIRSD/DOS3/CIR/P/2018/139 dated November 6, 2018 company wish to inform that on the request received from the transferee(s) T Varadhan and Pramod Kumar Agarwal, the transfer of below mentioned equity shares of the Company has been effected on 13th November, 2020 with a condition that these shares shall be under lock-in for a period of 6 months from the date of registration of transfer and should not be transferred / dematerialized during the said period. Date of Registration of Transfer of Shares Certificate no. & No. of Shares Distinctive Numbers Nominal value (each in Rs.) Ledger Folio of Transferor Transferor''s Name Ledger Folio of Transferee Transferee''s Name 13/11/2020 23679 & 1000 49453271-49454270 1 SPL003478 TWENTYFIRST CENTURY MANAGEMENT SER LTD SPL006871 T VARDHAN PRAMOD KUMAR AGARWAL This is for your information and record. SUVEN LIFE SCIENCES LTD. - 530239 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Company has received intimation from Shareholder regarding loss of share certificate(s) from the following shareholders(s). A copy of intimation letter enclosed herewith. Name of the Holder Folio No. No. of Shares Certificate No.(s) Distinctive Nos. date of receipt of information From To SATYANARAYANA RAO MARUPUDI SPL000173 5000 12891 49754405 49759404 29/10/2020 5000 22891 107387655 107392654 The above said shareholder(s) of these shares have requested the company to issue of duplicate share certificate(s) in lieu of the original share certificate(s). This is for your information and record. SUVEN LIFE SCIENCES LTD. - 530239 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, please find enclosed the copies of the newspaper advertisement regarding Un-audited Financial Results of the Company for quarter and half-year ended 30th September, 2020. The advertisements are as appeared on 28th September, 2020 in Business Standard and Andhra Prabha (Telugu). The above information will also be hosted on the website of the Company at: http://www.suven.com/newspaperads.aspx This is for your information and record. SUVEN LIFE SCIENCES LTD. - 530239 - Outcome Of The Board Meeting
With reference to the above subject, pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors of the company, at its meeting held today i.e. 27th October, 2020, has taken on record and approved the Un-audited Standalone and Consolidated Financial Results of the Company under Ind AS along with review reports of the Statutory Auditors for the quarter and half-year ended 30th September, 2020. We are enclosing herewith the following documents: a) Un-audited Standalone and Consolidated Financial Results under Ind AS for the quarter and half-year ended 30th September, 2020 b) Limited Review Reports of Statutory Auditors of the Company on the financial results as mentioned above and c) A copy of the Press Release of our company SUVEN LIFE SCIENCES LTD. - 530239 - Outcome Of The Board Meeting
With reference to the above subject, pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors of the company, at its meeting held today i.e. 27th October, 2020, has taken on record and approved the Un-audited Standalone and Consolidated Financial Results of the Company under Ind AS along with review reports of the Statutory Auditors for the quarter and half-year ended 30th September, 2020. We are enclosing herewith the following documents: a) Un-audited Standalone and Consolidated Financial Results under Ind AS for the quarter and half-year ended 30th September, 2020 b) Limited Review Reports of Statutory Auditors of the Company on the financial results as mentioned above and c) A copy of the Press Release of our company We request you to take these documents on your records. The Board Meeting commenced at 11:30 A.M. and concluded at 1:15 P.M. Suven Life Sciences Ltd - 530239 - Announcement under Regulation 30 (LODR)-Newspaper Publication
In continuation to our letter dated 20th October, 2020 regarding the Date and Notice of Board Meeting, please find enclosed the copies of the newspaper advertisements as appeared today i.e. 27th October, 2020 in Andhra Prabha (Telugu) and Business Standard. The above information will also be hosted on the website of the Company at: http://www.suven.com/NoticeofBoardMeeting.aspx This is for your information and record. Suven Life Sciences Ltd - 530239 - Board Meeting Intimation for Intimation Of Board Meeting Of The Company To Be Held On Tuesday, The 27Th October, 2020 - Reg.,
SUVEN LIFE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2020 ,inter alia, to consider and approve With reference to above subject, pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please note that a Meeting of the Board of Directors of the Company will be held on Tuesday, the 27th October, 2020 at 11:30 a.m. at the Registered Office of the Company at SDE Serene Chambers, 6th Floor, Road No 5, Banjara Hills, Hyderabad-500034, to consider, among other things, inter alia, and take on record the following matter(s): To consider and approve the Un-audited Financial Results (Standalone and Consolidated) of the Company under Ind AS for the quarter and half-year ended 30th September, 2020 and related matters. Please further note that TRADING WINDOW for dealing in the securities of the company is already closed from 01st October, 2020 as per PIT Code of the Company. Trading window will be opened from 30th October, 2020. You are requested to take this notice on your record.